EE9800227A - 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid - Google Patents
17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadidInfo
- Publication number
- EE9800227A EE9800227A EE9800227A EE9800227A EE9800227A EE 9800227 A EE9800227 A EE 9800227A EE 9800227 A EE9800227 A EE 9800227A EE 9800227 A EE9800227 A EE 9800227A EE 9800227 A EE9800227 A EE 9800227A
- Authority
- EE
- Estonia
- Prior art keywords
- amidandrostanes
- carbothio
- carboxy
- lactone derivatives
- lactone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9526651.6A GB9526651D0 (en) | 1995-12-29 | 1995-12-29 | Compounds |
| GBGB9613121.4A GB9613121D0 (en) | 1996-06-21 | 1996-06-21 | Compounds |
| PCT/GB1996/003140 WO1997024365A1 (en) | 1995-12-29 | 1996-12-19 | Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9800227A true EE9800227A (et) | 1998-12-15 |
Family
ID=26308402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9800227A EE9800227A (et) | 1995-12-29 | 1996-12-19 | 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6197761B1 (cs) |
| EP (1) | EP0876392B1 (cs) |
| JP (1) | JP2947944B2 (cs) |
| KR (1) | KR19990076859A (cs) |
| CN (1) | CN1133643C (cs) |
| AP (1) | AP9801274A0 (cs) |
| AT (1) | ATE194356T1 (cs) |
| AU (1) | AU721865B2 (cs) |
| BG (1) | BG102625A (cs) |
| BR (1) | BR9612309A (cs) |
| CA (1) | CA2241728A1 (cs) |
| CZ (1) | CZ207498A3 (cs) |
| DE (1) | DE69609199T2 (cs) |
| DK (1) | DK0876392T3 (cs) |
| EA (1) | EA001401B1 (cs) |
| EE (1) | EE9800227A (cs) |
| ES (1) | ES2150150T3 (cs) |
| GR (1) | GR3034564T3 (cs) |
| HU (1) | HUP9903707A3 (cs) |
| IL (1) | IL124938A0 (cs) |
| IS (1) | IS4781A (cs) |
| MX (1) | MX9805181A (cs) |
| NO (1) | NO311022B1 (cs) |
| NZ (1) | NZ324373A (cs) |
| OA (1) | OA10701A (cs) |
| PE (1) | PE87598A1 (cs) |
| PL (1) | PL327629A1 (cs) |
| PT (1) | PT876392E (cs) |
| SI (1) | SI0876392T1 (cs) |
| SK (1) | SK89198A3 (cs) |
| TR (1) | TR199801247T2 (cs) |
| TW (1) | TW498072B (cs) |
| WO (1) | WO1997024365A1 (cs) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0998484B1 (en) * | 1997-06-30 | 2004-03-03 | Glaxo Group Limited | Method of identifying compounds having reduced systemic effects |
| GB9909229D0 (en) * | 1999-04-23 | 1999-06-16 | Glaxo Group Ltd | Enantiomers of mercapto lactones and processes for their synthesis |
| GB0017988D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Novel process |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| KR100827379B1 (ko) * | 2000-08-05 | 2008-05-07 | 글락소 그룹 리미티드 | 항염증제로서의 6.알파., 9.알파.-디플루오로-17.알파.-'(2-푸라닐카르복실)옥시-11.베타.-히드록시-16.알파.-메틸-3-옥소-안드로스트-1,4-디엔-17-카르보티오산 ｓ-플루오로메틸 에스테르 |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| US7291608B2 (en) * | 2001-04-30 | 2007-11-06 | Glaxo Group Limited | Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α |
| WO2002100879A1 (en) * | 2001-06-12 | 2002-12-19 | Glaxo Group Limited | Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| WO2003018575A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase |
| GB0125259D0 (en) * | 2001-10-20 | 2001-12-12 | Glaxo Group Ltd | Novel compounds |
| GB0127160D0 (en) * | 2001-11-12 | 2002-01-02 | Glaxo Group Ltd | Novel compounds |
| WO2003042229A1 (en) * | 2001-11-12 | 2003-05-22 | Glaxo Group Limited | Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids |
| US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| EP1466920A1 (en) * | 2003-04-04 | 2004-10-13 | Alpharma APS | Process for the preparation of steroidal 17 beta-carbothioates |
| US20070270584A1 (en) * | 2003-04-04 | 2007-11-22 | Trond Loevli | Process for the Preparation of Steroidal Carbothioic Acid Derivatives and Intermediates |
| ATE401889T1 (de) * | 2004-04-01 | 2008-08-15 | Hoffmann La Roche | Verwendung von trioxopyrimidin zur behandlung und prävention von entzündlichen erkrankungen der bronchien |
| PT103202B (pt) | 2004-10-19 | 2011-01-27 | Hovione Farmaciencia S A | Processo para a esterificação de um ácido carbotiótico |
| GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
| AR059216A1 (es) * | 2006-01-27 | 2008-03-19 | Sun Pharmaceutical Ind Ltd | 11b-hidroxiandrosta-4-eno-3-onas |
| GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
| CN103087137A (zh) * | 2011-11-07 | 2013-05-08 | 天津金耀集团有限公司 | 一种21位为硫代烃基的糖皮质激素 |
| JPWO2023210608A1 (cs) | 2022-04-28 | 2023-11-02 | ||
| WO2024125639A1 (zh) * | 2022-12-16 | 2024-06-20 | 津药生物科技（天津）有限公司 | 新型糖皮质激素、其制备方法及用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4093721A (en) | 1974-08-30 | 1978-06-06 | Glaxo Laboratories Limited | Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof |
| US4188385A (en) | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
| SE8306370D0 (sv) | 1983-11-18 | 1983-11-18 | Draco Ab | Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions |
| IL78144A0 (en) | 1985-04-04 | 1986-07-31 | Draco Ab | Novel androstane-17beta-carboxylic acid esters |
| US5767113A (en) * | 1995-05-10 | 1998-06-16 | The Salk Institute For Biological Studies | Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance |
-
1996
- 1996-12-19 ES ES96942493T patent/ES2150150T3/es not_active Expired - Lifetime
- 1996-12-19 AP APAP/P/1998/001274A patent/AP9801274A0/en unknown
- 1996-12-19 IL IL12493896A patent/IL124938A0/xx unknown
- 1996-12-19 WO PCT/GB1996/003140 patent/WO1997024365A1/en not_active Ceased
- 1996-12-19 TR TR1998/01247T patent/TR199801247T2/xx unknown
- 1996-12-19 KR KR1019980704986A patent/KR19990076859A/ko not_active Withdrawn
- 1996-12-19 HU HU9903707A patent/HUP9903707A3/hu unknown
- 1996-12-19 SI SI9630232T patent/SI0876392T1/xx unknown
- 1996-12-19 PL PL96327629A patent/PL327629A1/xx unknown
- 1996-12-19 CZ CZ982074A patent/CZ207498A3/cs unknown
- 1996-12-19 DK DK96942493T patent/DK0876392T3/da active
- 1996-12-19 NZ NZ324373A patent/NZ324373A/en unknown
- 1996-12-19 DE DE69609199T patent/DE69609199T2/de not_active Expired - Fee Related
- 1996-12-19 EA EA199800484A patent/EA001401B1/ru not_active IP Right Cessation
- 1996-12-19 SK SK891-98A patent/SK89198A3/sk unknown
- 1996-12-19 EE EE9800227A patent/EE9800227A/xx unknown
- 1996-12-19 JP JP9524095A patent/JP2947944B2/ja not_active Expired - Fee Related
- 1996-12-19 EP EP96942493A patent/EP0876392B1/en not_active Expired - Lifetime
- 1996-12-19 PT PT96942493T patent/PT876392E/pt unknown
- 1996-12-19 AU AU11409/97A patent/AU721865B2/en not_active Ceased
- 1996-12-19 CA CA002241728A patent/CA2241728A1/en not_active Abandoned
- 1996-12-19 US US09/091,748 patent/US6197761B1/en not_active Expired - Fee Related
- 1996-12-19 CN CNB961801077A patent/CN1133643C/zh not_active Expired - Lifetime
- 1996-12-19 AT AT96942493T patent/ATE194356T1/de not_active IP Right Cessation
- 1996-12-19 BR BR9612309A patent/BR9612309A/pt not_active Application Discontinuation
-
1997
- 1997-06-26 TW TW086108975A patent/TW498072B/zh active
- 1997-06-27 PE PE1997000549A patent/PE87598A1/es not_active Application Discontinuation
-
1998
- 1998-06-19 OA OA9800089A patent/OA10701A/en unknown
- 1998-06-23 IS IS4781A patent/IS4781A/is unknown
- 1998-06-25 MX MX9805181A patent/MX9805181A/es unknown
- 1998-06-26 NO NO19983004A patent/NO311022B1/no not_active IP Right Cessation
- 1998-07-13 BG BG102625A patent/BG102625A/xx unknown
-
2000
- 2000-10-04 GR GR20000402254T patent/GR3034564T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9800227A (et) | 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid | |
| PT833828E (pt) | Derivados de rapamicina | |
| DE69522717D1 (de) | Chinazolinderivate | |
| DE69611361D1 (de) | Chinazolin-derivate | |
| BR9611130A (pt) | Derivados de 3-aril-5-halógeno-pirona | |
| NO974103D0 (no) | Arylsulfonylaminohydroksamsyre-derivater | |
| DE69610698D1 (de) | Chinazolin-derivate | |
| BR9611834A (pt) | Derivados de oximetóxi-3-aril-pirona | |
| BR9605434A (pt) | Derivados de purin-6-ona | |
| ATE199150T1 (de) | Diphenylmethylenpiperidin-derivate | |
| DE69601527D1 (de) | Pyrrolylbenzimidazol-Derivate | |
| ATA100695A (de) | Prothrombin-derivate | |
| PT856007E (pt) | Derivados de ciclopeptidos | |
| ATE224891T1 (de) | Chromon-derivate | |
| BR9610597A (pt) | Derivados de diarilalcenilamina | |
| DE69627830D1 (de) | Pyrazol-derivate | |
| BR9607046A (pt) | Derivados de 3-pirrolidiliden-2-ona-cefalosporinas | |
| DE59607054D1 (de) | 4-Amino-benzoylguanidin-Derivate | |
| DE69601611D1 (de) | Chromanderivate | |
| DE59610106D1 (de) | Fluorbenzylether-Derivate | |
| BR9609723A (pt) | Derivados da tricetona | |
| BR9603508A (pt) | Derivados de alquenil-benzoilguanidina | |
| PT843675E (pt) | Derivados de aza-antraciclinona | |
| EP0804205A4 (en) | 4-AZA-19-NORANDROSTANDERIVATE | |
| ATE202088T1 (de) | 4-mercapto-benzoylguanidin-derivate |